Serum prestin levels were significantly elevated prior to the onset of cisplatin-induced hearing loss in R1 compared to control, 8.049 ± 2.271 ng/mL (mean difference ± SEM) (p = 0.00182). This evidence concerns the gene SLC26A5 and hearing loss disorder.